Products

3D-(6-acyl) PHAD® | 699855

Monophosphoryl Hexa-acyl Lipid A, 3-Deacyl (Synthetic)

699855P

Powder

1 mg
$175.00
5 mg
$700.00
10 mg
$1260.00
25 mg
$2675.00

All Prices in US Dollars
Custom packaging is calculated at $4.00 per aliquot and will be charged at the time of shipping.

Custom Packaging: Before clicking add to cart, from the drop down arrow select custom packaging. Next, edit the quantities (and concentration for solutions) information. Finally, click add to cart.

  • Product
  • Data
  • Downloads
Vaccination is well-accepted as an effective method to prevent infections by mounting pathogen-specific immune responses prior to the infection. Usually, immunization with vaccine antigens alone is not able to induce robust or long-lasting immune responses — resulting in failure of protective immunity against infections. Thus, adjuvants are required to enhance cellular or humoral immune responses upon immunization. Because vaccine adjuvants using Lipid A have proven to be safe and effective in inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines, Avanti developed Phosphorylated HexaAcyl Disaccharide (PHAD®), the first fully synthetic monophosphoryl Lipid A available for use as an adjuvant in human vaccines.

Adjuvant Activity

Antigen: gp140 from HIV-1 PHAD®, 3D-PHAD®, and 3D(6A)-PHAD® have been tested extensively in animals using a variety of antigens. In all cases, these adjuvants exhibit a similar activity and safety profile to bacterially-derived MPL. The data above demonstrate the equivalency of the three synthetic adjuvants to the bacterially-derived MPL when presented in a liposomal carrier system (DMPC/DMPG/Cholesterol).
Molecular Formula
C96H184N3O21P
Percent Composition
C 65.98%, H 10.61%, N 2.40%, O 19.23%, P 1.77%
Purity
>99%
Stability
1 year
Storage
-20°C
Molecular Weight
1747.469
Exact Mass
1746.316
Download
Notes
GIF Graphics File.